Johnson & Johnson Agrees to $5.5 Billion Proposal to Settle Most U.S. Talc Ovarian Cancer Claims
Johnson & Johnson has reached a proposed agreement to settle the majority of its remaining U.S. ovarian cancer lawsuits tied to talc products. The company would commit $5.5 billion if at least 95% of claimants accept the deal, resolving roughly 76,000 claims. The pact includes a first payment of up to $3 billion in 2027 and reflects the company's d…